Live Breaking News & Updates on Professor Of Applied Physics At Stanford University

Cancer Liquid Biopsy Developer Bluestar Raises $70M, Adds Venter to Scientific Advisory Board
May 21, 2021
J. Craig Venter, Ph.D.
Bluestar Genomics, the developer of an epigenomic platform focused on early cancer detection, has raised $70 million in an oversubscribed Series C equity financing and named genomics pioneer J. Craig Venter, Ph.D., among two new members of its expanded scientific advisory board.
“Collectively, these milestones will extend our ability to deliver on our promise to improve on existing cancer screening and provide a new solution where none exists,” Samuel Levy, Ph.D., Bluestar’s CEO and Chief Scientific Officer, said in a statement. ....

Stanford University , United States , San Diego , University Of California San Francisco , San Francisco , Stephen Quake , Chan Zuckerberg Biohub , Felix Feng , Samuel Levy , J Craig Venter , Alan Ashworth , Helen Diller Comprehensive Cancer Center , University Of California , Nature Communications , J Craig Venter Institute , University Of Chicago , Professor Of Applied Physics At Stanford University , Chief Scientific Officer , Lee Otterson Professor , Applied Physics , Chan Zuckerberg , Human Genome Project , Venter Institute , Scientific Advisory Board , California San Francisco , Bluestar Genomic ,